Aptevo Therapeutics Inc. (APVO) Operating income 2016–2025
Aptevo Therapeutics Inc. (APVO) annual operating income history from SEC filings — each fiscal year as reported.
-$26.3MFY2025 · since FY2016: -$138.8M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | -7.0% |
| FY2024 | -$24.6M | +14.8% |
| FY2023 | -$28.9M | -0.8% |
| FY2022 | -$28.6M | -33.8% |
| FY2021 | -$21.4M | +22.2% |
| FY2020 | -$27.5M | +32.9% |
| FY2019 | -$41.0M | +20.7% |
| FY2018 | -$51.7M | +4.2% |
| FY2017 | -$53.9M | +61.1% |
| FY2016 | -$138.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice